Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study

Background: Remdesivir is effective against SARS-Cov-2 with little evidence of its adverse effect on the cardiac system. The aim of the present study is investigating the incidence of bradycardia in COVID-19 patients treated with Remdesivir. Methods: This prospective longitudinal study was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajimoradi, Maryam, Sharif Kashani, Babak, Dastan, Farzaneh, Aghdasi, Sina, Abedini, Atefeh, Naghashzadeh, Farah, Mohamadifar, Arezoo, Keshmiri, Mohammad Sadegh, Noorali, Sima, Lookzadeh, Somayeh, Alizadeh, Niloufar, Siri, Mohammad Amin, Tavasolpanahi, Mohammadali, Abdolmohammadi, Yazdan, Shafaghi, Masoud, Rouhani, Zahra Sadat, Shafaghi, Shadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888491/
https://www.ncbi.nlm.nih.gov/pubmed/36733376
http://dx.doi.org/10.3389/fphar.2022.1107198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888491/
https://www.ncbi.nlm.nih.gov/pubmed/36733376
http://dx.doi.org/10.3389/fphar.2022.1107198

Ejemplares similares